tiprankstipranks
Trending News
More News >
ASGN Incorporated (ASGN)
NYSE:ASGN

ASGN (ASGN) AI Stock Analysis

Compare
219 Followers

Top Page

ASGN

ASGN

(NYSE:ASGN)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
$53.00
▲(7.48% Upside)
ASGN scores as a balanced setup: financial performance is the key limiter due to declining revenue, compressed profitability, and negative free cash flow growth, despite a stable balance sheet. Offsetting this, the earnings call and recent acquisition/buyback news are supportive, while technicals and valuation look broadly neutral to modestly favorable.
Positive Factors
Balance-sheet strength
ASGN's moderate leverage and roughly 50% equity ratio provide durable financial flexibility. Manageable debt levels reduce refinancing and solvency risk through cycles, enabling the company to fund M&A, strategic investments, and buybacks without unduly stressing the capital structure over the next several quarters.
IT consulting market position
A dominant and growing IT consulting mix positions ASGN in secular digital transformation demand—AI, application development, cybersecurity—which typically have higher recurring project spend. This structural exposure supports steadier contractual demand and cross-sell opportunities versus purely transactional staffing models over the medium term.
Strategic M&A expands capabilities
The Quinnox deal adds a scaled offshore digital engineering platform, accelerating ASGN's AI/data and modernization capabilities while adding immediate revenue and low-20% adjusted EBITDA margin potential. This strengthens delivery footprint and margin mix, supporting durable competitive differentiation and revenue diversification.
Negative Factors
Sustained revenue decline
A near-50% TTM revenue decline is a structural red flag: it reduces operating scale, weakens pricing leverage, and limits reinvestment capacity. If persistent, shrinking top-line undermines margin recovery plans and makes achievement of multi-year growth targets and cash generation projections more challenging.
Compressed profitability
Material margin compression points to mix shifts, pricing pressure, or rising operating costs that impair sustainable profitability. Low net and falling operating margins diminish free cash flow potential, constrain capital allocation choices, and increase the sensitivity of returns to modest revenue volatility over the coming quarters.
Weak free cash flow growth
Negative FCF growth despite healthy conversion indicates slowing cash generation or working-capital strain. Continued declines in free cash flow would limit the firm's ability to self-fund acquisitions, sustain buybacks, or deleverage, raising execution risk for strategic initiatives that depend on internal cash over the medium term.

ASGN (ASGN) vs. SPDR S&P 500 ETF (SPY)

ASGN Business Overview & Revenue Model

Company DescriptionASGN Incorporated provides information technology services and professional solutions in the technology, digital, and creative fields for commercial and government sectors in the United States. It operates through two segments: Commercial and Federal Government. The Commercial Segment provides consulting, creative digital marketing, and permanent placement services primarily to Fortune 1000 and mid-market clients. This segment also offers workforce mobilization, modern enterprise, and digital innovation IT consulting services; and cloud, data and analytics, and digital transformation solutions. The Federal Government Segment provides mission-critical solutions to the department of defense, intelligence agencies, and civilian agencies. This segment offers cloud, cybersecurity, artificial intelligence, machine learning, application and IT modernization, and science and engineering solutions. The company was formerly known as On Assignment, Inc. and changed its name to ASGN Incorporated in April 2018. ASGN Incorporated was incorporated in 1985 and is based in Glen Allen, Virginia.
How the Company Makes MoneyASGN generates revenue primarily through its staffing and consulting services, which are billed on a time-and-materials basis or through fixed-fee contracts. The company earns fees from placing skilled professionals in temporary, contract, and permanent positions across multiple sectors, with a significant focus on IT and creative talent. Key revenue streams include billable hours worked by consultants and the placement fees for permanent hires. Additionally, ASGN benefits from long-term contracts with government agencies and private sector clients, which provide stable income. Partnerships with technology firms and other service providers further enhance ASGN's capabilities, enabling the company to offer comprehensive solutions and drive additional revenue growth.

ASGN Earnings Call Summary

Earnings Call Date:Oct 22, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 04, 2026
Earnings Call Sentiment Neutral
The earnings call presented a mixed picture with solid performance in IT consulting and healthcare sectors, but challenges in revenue decline, assignment revenues, and the potential impact of the government shutdown. The highlights and lowlights reflect a balanced outlook with positive growth prospects tempered by existing challenges.
Q3-2025 Updates
Positive Updates
Solid Revenue and EBITDA Performance
ASGN delivered solid performance in the third quarter, with revenues reaching $1.01 billion and an adjusted EBITDA margin of 11.1%, both at the high end of guidance ranges.
Growth in IT Consulting
The IT consulting business continues to be a key growth driver, representing approximately 63% of total revenues in the third quarter, up from 58% in the same period last year.
Increase in AI and Data Projects
ASGN has seen an increase in projects focused on data and AI, application development and engineering, customer experience, and cybersecurity, highlighting a significant commitment to digital advancement.
Healthcare Industry Performance
The healthcare industry saw the largest sequential growth, up high single digits as compared to the year ago, driven by healthcare provider, pharmaceutical, and biotech clients.
Strong Federal Segment Bookings
In the federal segment, new contract awards totaled $461 million for the third quarter, with a book-to-bill of 1.5 times for the quarter.
Negative Updates
Year-over-Year Revenue Decline
Revenues totaled $1.01 billion, a decrease of 1.9% year over year, with the commercial segment decreasing by 1% and the federal government segment by 3.9%.
Decrease in Assignment Revenues
Assignment revenues totaled $376.4 million, a decrease of 13.2% year over year, reflecting continued softness in portions of the commercial segment sensitive to macroeconomic cycles.
Challenges in Financial Services
Financial services experienced a year-over-year decline, although new wins for the industry outpaced renewals in Q3.
Impact of Government Shutdown
The government shutdown poses a potential headwind, slowing down the cycle of new awards and the ability to ramp up on awards just won.
Company Guidance
During the ASGN Incorporated Third Quarter 2025 Earnings Call, the company provided guidance highlighting strong performance and growth in various sectors. ASGN reported revenues of $1.01 billion with an adjusted EBITDA margin of 11.1%, both at the high end of their guidance ranges. The IT consulting business was a significant growth driver, accounting for 63% of total revenues, with commercial consulting bookings at $324 million and a book-to-bill ratio of 1.2 times. In the federal segment, new contract awards totaled $461 million, with a book-to-bill ratio of 1.5 times for the quarter. The company also emphasized the growing demand for AI and digital transformation, indicating that AI spending is becoming a core aspect of enterprise technology. Despite challenges such as organizational readiness and a shortage of technical talent, ASGN is well-positioned to leverage its capabilities, particularly with the potential positive impact from changes to the H-1B visa process. Looking forward, ASGN projected fourth-quarter revenues between $960 million and $980 million, with an adjusted EBITDA margin of 10.6% to 10.9%.

ASGN Financial Statement Overview

Summary
Moderate fundamentals: revenue is declining (-48.9% TTM) and profitability is under pressure (net margin 3.3% TTM; declining EBIT/EBITDA margins). Balance sheet leverage is manageable (debt-to-equity 0.64; equity ratio 49.5%), but ROE is down (7.2% TTM). Cash generation is mixed with negative FCF growth (-19.7% TTM) despite healthy FCF-to-net income (87%).
Income Statement
65
Positive
ASGN's income statement shows a declining revenue trend with a negative revenue growth rate of -48.9% TTM, indicating potential challenges in maintaining sales momentum. The gross profit margin remains stable around 28.9%, but the net profit margin has decreased to 3.3% TTM, reflecting reduced profitability. EBIT and EBITDA margins have also declined, suggesting operational inefficiencies. Overall, the income statement reflects moderate financial health with concerns about revenue and profit declines.
Balance Sheet
70
Positive
The balance sheet indicates a moderate debt-to-equity ratio of 0.64 TTM, showing manageable leverage. Return on equity has decreased to 7.2% TTM, which is lower than previous years, indicating reduced efficiency in generating profits from equity. The equity ratio stands at 49.5% TTM, suggesting a stable capital structure. While the balance sheet remains relatively strong, the declining ROE is a concern.
Cash Flow
60
Neutral
ASGN's cash flow statement shows a decline in free cash flow growth by -19.7% TTM, indicating potential cash generation issues. The operating cash flow to net income ratio is not available TTM, but the free cash flow to net income ratio is healthy at 87%. Despite a strong free cash flow to net income ratio, the negative growth in free cash flow raises concerns about future liquidity.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue3.99B4.10B4.45B4.58B4.01B3.50B
Gross Profit1.15B1.18B1.28B1.37B1.14B947.20M
EBITDA428.00M400.70M464.40M500.90M440.50M370.90M
Net Income130.70M175.20M219.30M268.10M409.90M200.30M
Balance Sheet
Total Assets3.70B3.43B3.54B3.59B3.50B3.28B
Cash, Cash Equivalents and Short-Term Investments126.50M205.20M175.90M70.30M529.60M274.40M
Total Debt1.24B1.10B1.11B1.12B1.10B1.11B
Total Liabilities1.87B1.65B1.65B1.68B1.64B1.69B
Stockholders Equity1.83B1.78B1.89B1.90B1.87B1.59B
Cash Flow
Free Cash Flow283.30M364.70M417.00M270.30M159.00M392.20M
Operating Cash Flow325.80M400.00M456.90M307.80M193.70M424.80M
Investing Cash Flow-348.60M-35.30M-40.50M-510.00M246.50M-219.00M
Financing Cash Flow-17.80M-333.20M-310.90M-256.50M-184.40M-29.00M

ASGN Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price49.31
Price Trends
50DMA
47.41
Positive
100DMA
47.47
Positive
200DMA
50.05
Negative
Market Momentum
MACD
0.72
Positive
RSI
50.16
Neutral
STOCH
47.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ASGN, the sentiment is Neutral. The current price of 49.31 is below the 20-day moving average (MA) of 49.55, above the 50-day MA of 47.41, and below the 200-day MA of 50.05, indicating a neutral trend. The MACD of 0.72 indicates Positive momentum. The RSI at 50.16 is Neutral, neither overbought nor oversold. The STOCH value of 47.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ASGN.

ASGN Risk Analysis

ASGN disclosed 29 risk factors in its most recent earnings report. ASGN reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

ASGN Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
75
Outperform
$2.53B35.168.18%0.80%6.98%-4.56%
67
Neutral
$2.16B16.637.25%-4.86%-25.15%
67
Neutral
$3.05B30.854.91%5.56%-42.38%
62
Neutral
$2.55B7.1312.33%-4.13%2143.48%
62
Neutral
$987.36M12.2615.40%19.88%51.03%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
47
Neutral
$1.77B-4.64-46.77%1.84%-27.74%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
ASGN
ASGN
49.31
-39.56
-44.51%
FORTY
Formula Systems
164.59
73.66
81.00%
GLOB
Globant SA
69.75
-137.28
-66.31%
DXC
DXC Technology
14.43
-7.11
-33.01%
AI
C3ai
13.13
-18.92
-59.03%
TASK
TaskUs
10.72
-6.20
-36.64%

ASGN Corporate Events

Business Operations and StrategyStock BuybackFinancial DisclosuresM&A Transactions
ASGN to Acquire Quinnox in Strategic Digital Expansion
Positive
Jan 20, 2026

On January 20, 2026, ASGN announced a definitive agreement to acquire Quinnox Inc., a Chicago-founded digital solutions provider with operations in India and the UK, for $290 million in cash, with closing expected in March 2026 subject to customary antitrust approvals. The deal adds a scaled offshore digital engineering platform, strengthens ASGN’s AI, data, and application modernization capabilities, and broadens its reach across complementary industries including financial services, energy, retail, transportation, and manufacturing, with Quinnox contributing roughly $100 million in 2025 revenue, low-to-mid teens expected revenue growth in 2026, and Adjusted EBITDA margins in the low 20% range, and is projected to be accretive to ASGN’s adjusted earnings per share in the first full year after closing. ASGN also updated its outlook for the fourth quarter of 2025, expecting revenue and Adjusted EBITDA to land at the high end of prior guidance, highlighted robust free cash flow conversion above its 60–65% target, and underscored a balanced capital allocation strategy that combines strategic M&A like the Quinnox acquisition with an aggressive $1 billion share repurchase program, of which $972 million remained after buying back 1.4 million shares in the quarter.

The most recent analyst rating on (ASGN) stock is a Hold with a $50.00 price target. To see the full list of analyst forecasts on ASGN stock, see the ASGN Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 20, 2026